{"title": "Vitamin B6", "author": null, "url": "https://lpi.oregonstate.edu/mic/vitamins/vitamin-B6", "hostname": "oregonstate.edu", "description": "Contents Summary Function Nervous system Hemoglobin synthesis Tryptophan metabolism Hormone function Nucleic acid synthesis Deficiency The RDA Disease Prevention Immune dysfuncti", "sitename": "Linus Pauling Institute", "date": "2014-04-22", "cleaned_text": "1. Dakshinamurti S, Dakshinamurti K. Vitamin B6. In: McCormick DB, Suttie Handbook of Vitamins. 4th ed. New CRC Press (Taylor Fracis Group); 2007:315-359. 2. Galluzzi L, Vacchelli E, Michels J, et al. Effects of vitamin B6 metabolism on oncogenesis, tumor progression and therapeutic responses. Oncogene. 2013;32(42):4995-5004. [(PubMed)](http://www.ncbi.nlm.nih.gov/pubmed/23334322) 3. McCormick DB. Vitamin B6. In: Bowman BA, Russell RM, eds. Present Knowledge in Nutrition. Vol. I. Washington, D.C.: International Life Sciences Institute; 2006:269-277. 4. Da Silva VR, Russell KA, Gregory JF 3rd. Vitamin B6. In: Erdman JW Jr., Macdonald IA, SH. 6. Shils M, Olson JA, Shike M, Ross AC, eds. Modern Nutrition in Health and Disease. 9th ed. Baltimore: Williams & Wilkins; 1999:413-422. 7. Clayton PT. B6-responsive disorders: a model of vitamin dependency. J Inherit [(PubMed)](http://www.ncbi.nlm.nih.gov/pubmed/16763894) 5'-phosphate and pyridoxal 5'-deoxymethylenephosphonate at the and NH2-terminal Gregory JF, 3rd. A mathematical model of tryptophan metabolism via the kynurenine pathway provides insights into the effects of vitamin B-6 deficiency, tryptophan loading, and Wei LN. Vitamin B6 conjugation to nuclear corepressor RIP140 and its role in gene regulation. Nat Chem 2007;3(3):161-165. [(PubMed)](http://www.ncbi.nlm.nih.gov/pubmed/17277785) 12. Leklem JE. Vitamin of Vitamins. New York: Marcel Decker Inc; 1991:341-378. 13. Hansen CM, Shultz TD, Kwak HK, Memon HS, Leklem JE. Assessment of vitamin B-6 status in young women consuming a controlled diet containing four levels of vitamin B-6 provides an estimated average requirement and recommended dietary allowance. J Nutr. 2001;131(6):1777-1786. [(PubMed)](http://www.ncbi.nlm.nih.gov/pubmed/11385067) 14. Food and Nutrition Board, Institute of Medicine. Vitamin B6. Dietary Reference Intakes: Ueland J. Mechanistic perspective on the relationship between pyridoxal 5'-phosphate B-6 deficiency impairs interleukin 2 production and lymphocyte proliferation in elderly adults. Am J Clin Nutr. supplementation: effect on in Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women. JAMA. 1998;279(5):359-364. [(PubMed)](http://www.ncbi.nlm.nih.gov/pubmed/9459468) 19. Ishihara J, Iso H, Inoue M, et al. Intake of folate, vitamin B6 and vitamin B12 and the risk of CHD: the Japan Public Health Center-Based Prospective Study Cohort I. J Am Coll Nutr. 2008;27(1):127-136. [(PubMed)](http://www.ncbi.nlm.nih.gov/pubmed/18460491) 20. Folsom AR, Nieto FJ, McGovern PG, et al. Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: the Atherosclerosis Risk in Communities (ARIC) study. Circulation. 1998;98(3):204-210. [(PubMed)](http://www.ncbi.nlm.nih.gov/pubmed/9697819) 21. Robinson K, Arheart K, Refsum H, et al. Low circulating folate and vitamin B6 concentrations: risk factors for stroke, peripheral vascular disease, and coronary artery disease. European COMAC Group.Circulation. 1998;97(5):437-443. [(PubMed)](http://www.ncbi.nlm.nih.gov/pubmed/9490237) 22. Robinson K, Mayer EL, Miller DP, et al. Hyperhomocysteinemia and low pyridoxal phosphate. Common and independent reversible risk factors for coronary artery disease. Circulation. 1995;92(10):2825-2830. [(PubMed)](http://www.ncbi.nlm.nih.gov/pubmed/7586248) 23. Lin PT, Cheng CH, Liaw Lee TW, Huang YC. Low pyridoxal 5'-phosphate is associated with increased risk of coronary artery disease. Nutrition. 2006;22(11-12):1146-1151. [(PubMed)](http://www.ncbi.nlm.nih.gov/pubmed/17045461) 24. Page JH, Ma J, Chiuve SE, et al. Plasma vitamin B(6) and risk of myocardial infarction in women. Circulation. PJ, Delport R, Potgieter HC. Vitamin requirements for the treatment of hyperhomocysteinemia in humans. J Nutr. 1994;124(10):1927-1933. [(PubMed)](http://www.ncbi.nlm.nih.gov/pubmed/7931701) Stacpoole PW, Gregory JF, 3rd. Moderate vitamin B-6 restriction does not alter postprandial methionine cycle rates of remethylation, transmethylation, and total transsulfuration but increases the fractional synthesis rate of cystathionine in healthy young men and women. J Nutr. 2011;141(5):835-842. [(PubMed)](http://www.ncbi.nlm.nih.gov/pubmed/21430249) 28. Huang T, Chen Y, Yang B, Yang J, Wahlqvist ML, Li D. Meta-analysis of B vitamin supplementation on homocysteine, Plasma folate but not vitamin B(12) or homocysteine et al. Folic acid and vitamin B12 are more effective than vitamin B6 in lowering fasting plasma homocysteine concentration in patients with coronary artery disease. Eur J Clin Nutr. 2004;58(3):481-487. [(PubMed)](http://www.ncbi.nlm.nih.gov/pubmed/14985687) 31. Bostom AG, Carpenter MA, Kusek JW, et al. Homocysteine-lowering and cardiovascular disease outcomes in kidney transplant recipients: primary results from the Folic Acid for Vascular Outcome Reduction in Transplantation trial. Circulation. 2011;123(16):1763-1770. [(PubMed)](http://www.ncbi.nlm.nih.gov/pubmed/21482964) 32. Qin X, Huo Y, Xie D, Hou F, Xu X, Wang X. Homocysteine-lowering therapy with folic acid is effective in cardiovascular disease prevention in patients with kidney disease: a meta-analysis of randomized controlled trials. Clin Nutr. Lewington S. Homocysteine and vascular disease: review of published results of the homocysteine-lowering trials. J Inherit Metab Dis. 2011;34(1):83-91. [(PubMed)](http://www.ncbi.nlm.nih.gov/pubmed/21069462) Karakitsiou Simancas-Racines D. Homocysteine-lowering interventions preventing cardiovascular events. Cochrane Database Syst Rev. 2013;1:CD006612. [(PubMed)](http://www.ncbi.nlm.nih.gov/pubmed/23440809) 35. Zhang C, Chi FL, Xie TH, Zhou YH. Effect of B-vitamin supplementation on Eikelboom Jamrozik K, and flow-mediated vasodilation al. Effect of homocysteine-lowering B vitamin treatment on angiographic progression of coronary artery disease: a Western Norway B Vitamin Intervention Trial (WENBIT) substudy. Am J Cardiol. 2010;105(11):1577-1584. [(PubMed)](http://www.ncbi.nlm.nih.gov/pubmed/20494665) 38. Wang X, Qin X, Demirtas H, et al. Efficacy of folic acid supplementation in stroke prevention: a meta-analysis. Lancet. 2007;369(9576):1876-1882. [(PubMed)](http://www.ncbi.nlm.nih.gov/pubmed/17544768) 39. Vitatops Trial Study Group. B vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial: a randomised, Eikelboom JW, Yi Q, et al. Antiplatelet therapy and the effects of B vitamins in patients with previous stroke or transient ischaemic attack: a post-hoc Jacques PF, Picciano MF, Selhub J. Vitamin B-6 intake is inversely related to, and the requirement is affected by, inflammation status. J Nutr. 2010;140(1):103-110. [(PubMed)](http://www.ncbi.nlm.nih.gov/pubmed/19906811) 42. Sakakeeny L, Roubenoff R, Obin M, et al. Plasma pyridoxal-5-phosphate is inversely associated with systemic markers of inflammation in a population of US adults. J Nutr. 2012;142(7):1280-1285. [(PubMed)](http://www.ncbi.nlm.nih.gov/pubmed/22623384) 43. Shen J, Lai CQ, JM, Tucker KL. Association of vitamin B-6 status with inflammation, oxidative stress, and chronic inflammatory conditions: the Boston Puerto Rican Health Study. Am J Clin Nutr. 2010;91(2):337-342. [(PubMed)](http://www.ncbi.nlm.nih.gov/pubmed/19955400) Fuchs D. Total homocysteine in patients with angiographic coronary artery disease correlates with inflammation markers. Thromb Haemost. [(PubMed)](http://www.ncbi.nlm.nih.gov/pubmed/20216983) 45. Hartman J, Frishman WH. atherosclerosis: a review of the role of interleukin-6 in the development of atherosclerosis and the potential for targeted drug therapy. Cardiol Rev. 2014;22(3):147-151. [(PubMed)](http://www.ncbi.nlm.nih.gov/pubmed/24618929) 46. Friso S, Girelli D, Martinelli N, et al. Low plasma vitamin B-6 concentrations and modulation of coronary artery disease risk. Am J Clin Nutr. 2004;79(6):992-998. [(PubMed)](http://www.ncbi.nlm.nih.gov/pubmed/15159228) Nygard O, Ueland PM. Evidence for increased catabolism of vitamin B-6 during systemic inflammation. Am J AG, Grundt H, et al. Homocysteine-lowering therapy does not affect inflammatory markers of atherosclerosis in patients with stable coronary artery disease. J Intern Med. 2007;262(2):244-253. [(PubMed)](http://www.ncbi.nlm.nih.gov/pubmed/17645592) 49. Potter K, Lenzo N, Eikelboom JW, Beer C, Hankey GJ. Effect of long-term homocysteine reduction with B vitamins on arterial wall inflammation assessed by fluorodeoxyglucose positron Rosenberg IH. B vitamins, homocysteine, and neurocognitive function in the elderly. J 2000;71(2):614S-620S. 51. Pawelec G, Curr Opin Immunol. 2014;29C:23-28. [(PubMed)](http://www.ncbi.nlm.nih.gov/pubmed/24762450) 52. Ford AH, Almeida OP. Effect of homocysteine lowering treatment on cognitive function: a systematic review and meta-analysis of randomized controlled trials. J Alzheimers Dis. 2012;29(1):133-149. [(PubMed)](http://www.ncbi.nlm.nih.gov/pubmed/22232016) 53. Hankey GJ, Ford AH, Yi Q, et al. Effect of B vitamins and lowering homocysteine on cognitive impairment in patients with previous stroke or transient ischemic attack: a prespecified secondary analysis of a meta-analysis. 2013;44(8):2232-2239. [(PubMed)](http://www.ncbi.nlm.nih.gov/pubmed/23765945) 54. Douaud H, de CA, al. Preventing matter atrophy by B-vitamin U 2013;110(23):9523-9528. [(PubMed)](http://www.ncbi.nlm.nih.gov/pubmed/23690582) 55. Hackett ML, Yapa C, Parag V, Anderson CS. Frequency of depression after stroke: a systematic review of observational studies. Stroke. 2005;36(6):1330-1340. [(PubMed)](http://www.ncbi.nlm.nih.gov/pubmed/15879342) 56. Lenze EJ, Munin MC, Skidmore ER, et al. Onset of depression in elderly persons after hip fracture: implications for prevention and early intervention of late-life depression. J Am Geriatr Soc. 2007;55(1):81-86. [(PubMed)](http://www.ncbi.nlm.nih.gov/pubmed/17233689) 57. Merete C, Falcon LM, Tucker KL. Vitamin B6 is associated with depressive symptomatology in Massachusetts elders. J Am Coll Nutr. 2008;27(3):421-427. [(PubMed)](http://www.ncbi.nlm.nih.gov/pubmed/18838531) Pan WH, Chang YP, al. Co-occurrence of anemia, marginal vitamin B6, and folate status and depressive symptoms in older adults. J Geriatr Psychiatry Neurol. 2012;25(3):170-178. [(PubMed)](http://www.ncbi.nlm.nih.gov/pubmed/23124011) 59. Skarupski KA, Tangney C, Li H, Ouyang B, Evans DA, Morris MC. Longitudinal association of vitamin B-6, folate, and vitamin B-12 with depressive symptoms among older adults over time. Am J Clin Nutr. 2010;92(2):330-335. [(PubMed)](http://www.ncbi.nlm.nih.gov/pubmed/20519557) 60. Almeida OP, Marsh K, Alfonso H, Flicker L, Davis TM, Hankey GJ. B-vitamins reduce the long-term risk of depression after trial. a meta-analysis of prospective studies. JAMA. 2010;303(11):1077-1083. [(PubMed)](http://www.ncbi.nlm.nih.gov/pubmed/20233826) 62. Wu W, Kang S, Zhang D. Association of vitamin B6, vitamin B12 and methionine with risk of breast cancer: a dose-response meta-analysis. Br J Cancer. 2013;109(7):1926-1944. [(PubMed)](http://www.ncbi.nlm.nih.gov/pubmed/23907430) 63. Q, Freedman ND, Ren J, CC, Park folate, methionine, vitamin B6, and vitamin B12 with risk of esophageal and gastric cancer in a large cohort study. Br J Cancer. 2014;110(5):1328-1333. [(PubMed)](http://www.ncbi.nlm.nih.gov/pubmed/24481406) 64. Zhang XH, Ma J, Smith-Warner SA, Lee JE, Giovannucci E. Vitamin B6 and colorectal cancer: current evidence and future directions. World J Gastroenterol. 2013;19(7):1005-1010. [(PubMed)](http://www.ncbi.nlm.nih.gov/pubmed/23467420) 65. Song Y, Manson JE, Lee IM, et al. Effect of combined folic acid, vitamin B(6), and vitamin of vitamins B6 and C and the risk of kidney stones in women. J Am Soc Nephrol. 1999;10(4):840-845. [(PubMed)](http://www.ncbi.nlm.nih.gov/pubmed/10203369) 67. Taylor EN, Stampfer MJ, Curhan GC. Dietary factors and the risk of incident kidney stones in men: new insights after 14 years of follow-up. J Am Soc Nephrol. 2004;15(12):3225-3232. [(PubMed)](http://www.ncbi.nlm.nih.gov/pubmed/15579526) 68. Hudson BG, Voziyan PA. Pyridoxamine lowers kidney crystals in experimental hyperoxaluria: a potential therapy for primary hyperoxaluria. Kidney Int. 2005;67(1):53-60. 69. Scheinman JI, BG. lowers oxalate excretion and kidney crystals in experimental hyperoxaluria: a potential therapy for primary hyperoxaluria. Urol Res. 2005;33(5):368-371. 70. or S, Plecko B, al. Pyridoxine dependent epilepsy and antiquitin deficiency: clinical and molecular characteristics and recommendations for diagnosis, follow-up. Ardinger HH, et al., eds. GeneReviews\u00ae. Seattle, Washington: University of Washington, Seattle 1993-2014. [(PubMed)](http://www.ncbi.nlm.nih.gov/pubmed/20301697) 73. Maltepe C, Koren G. The management of nausea and vomiting of pregnancy and hyperemesis gravidarum--a 2013 Evidence-based view of safety and effectiveness of pharmacologic therapy for nausea and vomiting of pregnancy (NVP). Rose N, Niebyl J. Vitamin B6 is effective therapy for nausea and vomiting of and vomiting of Matthews A, Haas DM, O'Mathuna DP, Dowswell T, Doyle M. Interventions for nausea and vomiting in early pregnancy. Cochrane Database Syst Rev. 2014;3:CD007575. [(PubMed)](http://www.ncbi.nlm.nih.gov/pubmed/24659261) 78. Koren G, et al. Effectiveness of delayed-release doxylamine and pyridoxine for nausea and vomiting of pregnancy: a randomized placebo controlled trial. Am 79. Wyatt KM, Dimmock PW, Shaughn O'Brien PM. Efficacy of vitamin B-6 in the treatment of premenstrual syndrome: systematic [(PubMed)](http://www.ncbi.nlm.nih.gov/pubmed/10334745) 80. Whelan AM, Jurgens TM, Naylor H. Herbs, vitamins and minerals in the treatment of premenstrual syndrome: a systematic review. Can J Clin Pharmacol. 2009;16(3):e407-429. [(PubMed)](http://www.ncbi.nlm.nih.gov/pubmed/19923637) 81. Gariballa S, Forster S. Effects of dietary supplements on depressive symptoms in older patients: a homocysteine-induced neurotransmitter deficiency, and depression of mood hypothesis in clinical practice. Age Ageing. 2011;40(6):702-705. [(PubMed)](http://www.ncbi.nlm.nih.gov/pubmed/21771745) 83. Ellis J, Folkers K, Watanabe T, et al. Clinical results of a cross-over treatment with pyridoxine and placebo of the carpal tunnel syndrome. Am J Nutr. Folkers K. Vitamin B6 deficiency in patients with a clinical syndrome including the carpal tunnel defect. Biochemical and clinical response to therapy with RS. Vitamin B6, vitamin C, and carpal tunnel syndrome. A cross-sectional study of 441 adults. J Occup Environ Med. 1997;39(10):949-959. [(PubMed)](http://www.ncbi.nlm.nih.gov/pubmed/9343760) hydrochloride syndrome: a review. 2004;62(3):96-104. [(PubMed)](http://www.ncbi.nlm.nih.gov/pubmed/15098856) 87. M, W. vitamin B6. Can Fam Physician. 2007;53(7):1161-1162. [(PubMed)](http://www.ncbi.nlm.nih.gov/pubmed/17872812) 88. Morris Jacques Selhub J. Plasma pyridoxal 5'-phosphate in the US population: the National Health and Nutrition Examination Survey, 2003-2004. Am J Clin Nutr. 2008;87(5):1446-1454. [(PubMed)](http://www.ncbi.nlm.nih.gov/pubmed/18469270) 89. DR, for Nutritional Supplements. Montvale: Medical Economics Company, Inc; 2001. 90. Bender DA. Non-nutritional uses of vitamin B6. J Nutr. 1999;81(1):7-20 [(PubMed)](http://www.ncbi.nlm.nih.gov/pubmed/10341670) 91. Chang HY, Tang FY, Chen DY, et al. Clinical use of cyclooxygenase inhibitors impairs vitamin B-6 metabolism. levels of homocysteine, folate, vitamin B6 and B12 in women using oral contraceptives compared to non-users. Thromb Res. 2003;112(1-2):37-41. [(PubMed)](http://www.ncbi.nlm.nih.gov/pubmed/15013271) 93. Wilson SM, Bivins BN, Oral contraceptive use: on folate, vitamin B(6), B(1)(2) status. Nutr Rev. 2011;69(10):572-583. [(PubMed)](http://www.ncbi.nlm.nih.gov/pubmed/21967158) 94. Villegas-Salas E, Ponce de Leon R, Juarez-Perez MA, Grubb GS. Effect of vitamin B6 on the side effects of a low-dose combined oral contraceptive. Contraception. 1997;55(4):245-248. [(PubMed)](http://www.ncbi.nlm.nih.gov/pubmed/9179457) Gershoff SN. Vitamin B-6 requirements "}